Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to obtain data of the coadministration of ezetimibe and
rosuvastatin to support the concomitant use of these two drugs in patients requiring
additional cholesterol-lowering management. Treatment is administered for 14 days.